Evidence-Based Complementary and Alternative Medicine / 2020 / Article / Tab 1

Research Article

Assessment of the Efficacy and Safety of Ivy Leaf (Hedera helix) Cough Syrup Compared with Acetylcysteine in Adults and Children with Acute Bronchitis

Table 1

Demographic data.

EA 575®ACCTotal value

Age (years)
N11821139
Adults90; 76.3%19; 90.5%109; 78.4%NS
Children28; 23.7%2; 9.5%30; 21.6%
Average (years; range)44.3; 6–9549.1; 9–9045.0; 6–95NS
Sex (m/w)
N11821139
Male47; 39.8%11; 52.4%58; 41.7%NS
Female71; 60.2%10; 47.6%81; 58.3%
Height (cm)
N11821139
Mean ± SEM161.7 ± 1.8168 ± 2.5162.6 + 1.2NS
Weight (kg)
N11721138
Average (±SEM66.1 + 1.971.7 ± 4.566.9 ± 1.7NS
Ethnic
Caucasian103; 88.0%16; 76.2%119; 86.2%NS
Asian3; 2.6%0; 0%3; 2.2%
Black1; 0.9%2; 9.5%3; 2.2%
Other10; 8.5%3; 14.3%13; 9.4%
Total117; 100%21; 100%138; 100%

Analysis of variance or chi-squared test, as appropriate; NS = not significant (e.g. ); N = number of subjects.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.